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In many medical studies, patients are followed longitudinally and
interest is on assessing the relationship between longitudinal measure-
ments and time to an event. Recently, various authors have proposed
joint modeling approaches for longitudinal and time-to-event data
for a single longitudinal variable. These joint modeling approaches
become intractable with even a few longitudinal variables. In this pa-
per we propose a regression calibration approach for jointly modeling
multiple longitudinal measurements and discrete time-to-event data.
Ideally, a two-stage modeling approach could be applied in which the
multiple longitudinal measurements are modeled in the first stage and
the longitudinal model is related to the time-to-event data in the sec-
ond stage. Biased parameter estimation due to informative dropout
makes this direct two-stage modeling approach problematic. We pro-
pose a regression calibration approach which appropriately accounts
for informative dropout. We approximate the conditional distribu-
tion of the multiple longitudinal measurements given the event time
by modeling all pairwise combinations of the longitudinal measure-
ments using a bivariate linear mixed model which conditions on the
event time. Complete data are then simulated based on estimates
from these pairwise conditional models, and regression calibration is
used to estimate the relationship between longitudinal data and time-
to-event data using the complete data. We show that this approach
performs well in estimating the relationship between multivariate lon-
gitudinal measurements and the time-to-event data and in estimating
the parameters of the multiple longitudinal process subject to infor-
mative dropout. We illustrate this methodology with simulations and
with an analysis of primary biliary cirrhosis (PBC) data.
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1. Introduction. Recently, many studies collect longitudinal data on a
panel of biomarkers, and interest is on assessing the relationship between
these biomarkers and time to an event. For example, Allen et al. (2007)
examined the relationship between five longitudinally collected cytokines
measured from serum plasma and survival. Interest focused on whether the
values of these multiple cytokines are associated with survival. In another
example, patients with primary biliary cirrhosis are followed longitudinally
and interest is on examining whether multiple longitudinally biomarkers are
prognostic for a poor clinical outcome. Important features in studies of this
type are that there may be a relatively large number of biomarkers and that
these biomarkers are subject to sizable measurement error due to laboratory
error and biological variation.
Various authors have proposed joint modeling approaches for a single
longitudinal measurement and time-to-event data [Tsiatis, DeGruttola and
Wulfsohn (1995); Wulfsohn and Tsiatis (1997); Tsiatis and Davidian (2004);
Henderson, Diggle and Dobson (2000), among others]. There is also limited
work on joint models for a few longitudinal measurements and time-to-event
data [Xu and Zeger (2001a, 2001b); Huang et al. (2001); Song, Davidian
and Tsiatis (2002); Ibrahim, Chen and Sinha (2004); Brown, Ibrahim and
DeGruttola (2005); Chi and Ibrahim (2006)]. However, these methods are
difficult to implement when the number of longitudinal biomarkers is large
since most of these approaches require integrating over the vector of all ran-
dom effects to evaluate the joint likelihood of the multivariate longitudinal
and time-to-event data. This paper proposes an approach for jointly mod-
eling multivariate longitudinal and discrete time-to-event data which easily
accommodates many longitudinal biomarkers.
Fieuws and Verbeke (2005) and Fieuws, Verbeke and Molenberghs (2007)
have proposed an approach for modeling multivariate longitudinal data
whereby all possible pairs of longitudinal data are separately modeled and
are then combined in a final step. We use a similar approach along with a
recent regression calibration approach for jointly modeling a single series of
longitudinal measurements and time-to-event data [Albert and Shih (2009)]
to implement the joint modeling approach proposed in this paper. Recently,
Fieuws et al. (2008) have proposed a discriminant analysis based approach
for using multivariate longitudinal profiles to predict renal graft failure. At
the end of their discussion, they mention that a more elegant approach,
which has not yet been developed, would involve a joint model for the many
longitudinal profiles and time-to-event data. This paper presents such an
approach.
We describe the approach in Section 2. We show the advantages of this
approach using simulation in Section 3. We illustrate the methodology with
an analysis of primary biliary cirrhosis data (PBC) in which we simultane-
ously examine the relationship between multiple longitudinal biomarker in
Section 4. A discussion follows in Section 5.
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2. Modeling approach. Define Ti to be a discrete event-time which can
take on discrete values tj , j = 1,2, . . . , J , and Yij to be a binary indictor of
whether the ith patient is dead at time tj . Then Ji =
∑J
j=1(1−Yij) = J−Yi·,
where Yi· =
∑J
j=1Yij indicates the number of follow-up measurements before
the event or the end of follow-up at time tJ . Longitudinal measurements are
measured at times t1, t2, . . . , tJi . Denote X1i = (X1i1,X1i2, . . . ,X1iJi)
′, X2i =
(X2i1,X2i2, . . . ,X2iJi)
′, . . . ,XPi = (XPi1,XPi2, . . . ,XPiJi)
′ as the P biomark-
ers measured repeatedly at j = 1,2, . . . , Ji time points. Further, define X
∗
pi =
(X∗pi1,X
∗
pi2, . . . ,X
∗
piJi
)′ as the longitudinal measurements without measure-
ment error for the pth biomarker and X∗i = (X
∗
1i,X
∗
2i, . . . ,X
∗
Pi). We consider
a joint model for multivariate longitudinal and discrete time-to-event data
in which the discrete event time distribution is modeled as a linear function
of previous true values of the biomarkers without measurement error on the
probit scale. Specifically,
P (Yij = 1|Yi(j−1) = 0;X∗i ) = Φ
(
α0j +
P∑
p=1
αpX
∗
pi(j−1)
)
,(1)
where i= 1,2, . . . , I , j = 2,3, . . . , Ji, Yi1 is taken as 0, α0j governs the base-
line discrete event time distribution and αp measures the effect of the pth
biomarker (p= 1,2, . . . , P ) at time tj−1 on survival at time tj . Specifically,
(1) allows for examining the effect of multiple “true” biomarker values at
time j− 1 on the probability of an event between the (j− 1)th and jth time
point.
The longitudinal data is modeled assuming that the fixed and random ef-
fect trajectories are linear. Specifically, the multivariate longitudinal biomark-
ers can be modeled as
Xpij =X
∗
pij + εpij ,(2)
where
X∗pij = βp0 + βp1tj + γpi0 + γpi1tj ,(3)
where βp0 and βp1 are the fixed effect intercept and slope for the pth
biomarker, and γpi0 and γpi1 are the random effect intercept and slope for the
pth biomarker on the ith individual. Denote β = (β10, β11, β20, β21, . . . , βP0,
βP1)
′ and γi = (γ1i0, γ1i1, γ2i0, γ2i1, . . . , γPi0, γPi1)
′. We assume that γi is
normally distributed with mean 0 and variance Σγ , where Σγ is a 2P
by 2P dimensional variance matrix, and εpij are independent error terms
which are assumed to be normally distributed with mean 0 and variance σ2pε
(p= 1,2, . . . , P ).
Alternative to (1), where the probability of an event over an interval
depends on the true biomarker values at the beginning of the interval, the
event-time process could be adapted to depend on the random effects of the
multivariate longitudinal process [e.g., γpi1 can replace X
∗
pi(j−1) in (1)].
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2.1. Difficulty in joint estimation. Conceptually, model (1)–(2) can be
estimated by maximizing the likelihood
L=
I∏
i=1
∫
γi
· · ·
∫ { P∏
p=1
h(Xpi|γpi0, γpi1)
}
(4)
×
{
Ji∏
j=2
(1− rij)
}
(ri(Ji+1))
Ji<Jf(γi)dγi,
where rij = P (Yij = 1|Yi(j−1) = 0), h(Xpi|γpi0, γpi1) is the product of Ji uni-
variate normal density functions each with mean X∗pij and variance σ
2
pε, and
f(γ) is a multivariate normal density with mean zero and varianceΣγ . When
P = 1, (4) can be maximized by numerical integration techniques such as
a simple trapezoidal rule or Gaussian quadrature [Abramowitz and Stegun
(1974)]. However, these methods are not feasible for even a few longitudinal
biomarkers. Alternative Monte Carlo methods such as Monte Carlo EM [Wei
and Tanner (1990)] are possible, but these methods do not perform well for
even moderately high dimensional random effects (say, P > 2). In the next
subsection we develop an alternative approach which is easy to implement
with a large number of longitudinal biomarkers.
2.2. Estimation. We propose a two stage regression calibration approach
for estimation, which can be described as follows. In the first stage, multi-
variate linear mixed models can be used to model the longitudinal data. In
the second stage, the time-to-event model is estimated by replacing the ran-
dom effects with corresponding empirical Bayes estimates. There are three
problems with directly applying this approach. First, estimation in the first
stage is complicated by the fact that simply fitting multivariate linear mixed
models results in bias due to informative dropout; this is demonstrated by
Albert and Shih (2009) for the the case of P = 1. Second, as described in
Section 2.1, parameter estimation for multivariate linear mixed models can
be computationally difficult when the number of longitudinal measurements
(P ) is even moderately large. Third, calibration error in the empirical Bayes
estimation needs to be accounted for in the time-to-event model. The pro-
posed approach will deal with all three of these problems.
The bias from informative dropout is a result of differential follow-up
whereby the longitudinal process is related to the length of follow-up. That
is, in (2)–(3), patients with large values of X∗pij are more likely to have
an early event when αp > 0 for p = 1,2, . . . , P . There would be no bias if
all J follow-up measurements were observed on all patients. As proposed
by Albert and Shih (2009) for univariate longitudinal data, we can avoid
this bias by generating complete data from the conditional distribution of
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Xi = (X1i,X2i, . . . ,XPi) given Ti, denoted asXi|Ti. SinceXi|Ti under model
(2)–(3) does not have a tractable form, we propose a simple approximation
for this conditional distribution. Under model (2)–(3), the distribution of
Xi|Ti can be expressed as
P (Xi|Ti) =
∫
h(Xi|γi, Ti)g(γ i|Ti)dγi.(5)
Since Ti and the values of Xi are conditional independent given γi,
h(Xi|γi, Ti) = h(Xi|γi), where h(Xi|γi) =
∏P
p=1 h(Xpi|γpi0, γpi1). The distri-
bution of Xi|Ti can be expressed as a multivariate linear mixed model if we
approximate g(γi|Ti) by a normal distribution. Under the assumption that
g(γ i|Ti) is normally distributed with mean µTi = (µ01Ti , µ11Ti , µ02Ti , µ12Ti ,
. . . , µ0PTi , µ1PTi)
′ and variance Σ∗
γTi
, and by rearranging mean structure pa-
rameters in the integrand of (5) so that the random effects have mean zero,
Xi|Ti corresponds to the following multivariate linear mixed model:
Xpij|(Ti, γ∗ip0Ti , γ∗ip1Ti) = β∗p0Ti + β∗p1Titj + γ∗ip0Ti + γ∗ip1Titj + ε∗pij ,(6)
where i = 1,2, . . . , I , j = 1,2, . . . , Ji, and p = 1,2, . . . , P . The parameters
β∗p0Ti and β
∗
p1Ti
are intercept and slope parameters for the pth longitudi-
nal measurement and for patients who have an event time at time Ti or
who are censored at time tJ . In addition, the associated random effects
γ∗iTi = (γ
∗
i10Ti
, γ∗i11Ti , γ
∗
i20Ti
, γ∗i21Ti , . . . , γ
∗
iP0Ti
, γ∗iP1Ti)
′ are multivariate normal
with mean 0 and variance Σ∗
γTi
, and the residuals ε∗pij are assumed to have
an independent normal distribution with mean zero and variance σ∗2εp . Thus,
this conditional model involves estimating separate fixed effect intercept
and slope parameters for each potential event-time and for subjects who are
censored at time tJ . Likewise, separate random effects distributions are esti-
mated for each of these discrete time points. For example, the intercept and
slope fixed-effect parameters for the pth biomarker for those patients who
have an event at time Ti = t3 is β
∗
p0t3 and β
∗
p1t3 , respectively. Further, the
intercept and slope random effects for all P biomarkers on those patients
who have an event at time Ti = t3,γ
∗
it3
, is multivariate normal with mean
0 and variance Σ∗γt3 . A similar approximation has been proposed by Albert
and Shih (2009) for univariate longitudinal data (P = 1).
Recall that by generating complete data from (6) we are able to avoid the
bias due to informative dropout. However, when P is large, direct estimation
of model (6) is difficult since the number of elements in Σ∗
γTi
grows quadrat-
ically with P . For example, the dimension of the variance matrix Σ∗
γTi
is 2P
by 2P for P longitudinal biomarkers. Fieuws and Verbeke (2005) proposed
estimating the parameters of multivariate linear mixed models by formu-
lating bivariate linear mixed models on all possible pairwise combinations
of longitudinal measurements. In the simplest approach, they proposed fit-
ting bivariate linear mixed models on all
(
P
2
)
combinations of longitudinal
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biomarkers and averaging “overlapping” or duplicate parameter estimates.
Thus, we estimate the parameters in the fully specified model (6) by fitting(
P
2
)
bivariate longitudinal models that only include pairs of longitudinal
markers. Fieuws and Verbeke (2005) demonstrated with simulations that
there is little efficiency loss using their approach relative to a full maximum-
likelihood based approach. Fitting these bivariate models is computation-
ally feasible since only four correlated random effects are contained in each
model. (That is, Σ∗
γTi
is a four by four-dimensional matrix for each dis-
crete event-time Ti.) Duplicate estimates of fixed effects and random-effect
variances from all pairwise bivariate models are averaged to obtain final pa-
rameter estimates of the fully specified model (6). For example, when P = 4
there are (P − 1) = 3 estimates of β∗p0Ti , β∗p1Ti , σ∗2εp for the pth longitudinal
biomarker that need to be averaged.
Model (6) is then used to construct complete longitudinal pseudo data sets
which in turn are used to estimate the mean of the posterior distribution of
an individual’s random effects given the data. Specifically, multiple complete
longitudinal data sets can be constructed by simulating Xpij values from the
approximation to the distribution ofXi|Ti given by (6) where the parameters
are replaced by their estimated values. Since the simulated data sets have
complete follow-up on each individual, the bias in estimating the posterior
mean of γi caused by informative dropout will be much reduced.
The posterior mean of distribution γi given the data can be estimated by
fitting (2)–(3) to the generated complete longitudinal pseudo data. However,
similar to fitting the conditional model (6), fitting model (2)–(3) is difficult
due to the high dimension of Σγ . Thus, we again use the pairwise estimation
approach of Fieuws and Verbeke (2005), whereby we estimate the parameters
of (2)–(3) by fitting all pairwise bivariate models and averaging duplicate
parameter estimates to obtain final parameter estimates. For each generated
complete longitudinal pseudo data set, the estimate of the posterior mean,
denoted as γ̂i = (γ̂1i0, γ̂1i1, . . . , γ̂Pi0, γ̂Pi1)
′, can be calculated as
γ̂i =ΣγZ
′
iV
−1
i (Xi −Ziβ̂),(7)
where Zi is a PJ×2P design matrix corresponding to the fixed and random
effects in (2)–(3), where Zi = diag(A
′,A′, . . . ,A′)︸ ︷︷ ︸
P times
, A =
(
1
t1
1
t2
···
···
1
tJ
)
, and
Vi is the variance of Xi. Estimates of X
∗
pij , denoted as X̂
∗
pij , are obtained
by substituting (β̂p0, β̂p1, γ̂pi0, γ̂pi1) for (βp0, βp1, γpi0, γpi1) in (3).
To account for the measurement error in using γ̂i as compared with using
γi in (1), we note that
P (Yij = 1|Yi(j−1) = 0; X̂∗i ) = Φ
(
α0j +
∑P
p=1αpX̂
∗
pij√
1 +Var{∑Pp=1αp(X̂∗pij −X∗pij)}
)
,(8)
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where Var{∑Pp=1ωp(X̂∗pi(j−1) −X∗pi(j−1)} = R′ij Var(γ̂i − γi)Rij , Rij = (ω1,
ω1tj−1, ω2, ω2tj−1, . . . , ωp, ωptj−1), Var(γ̂i−γi) =Σγ−ΣγZ′i{V−1i Zi−V−1i ×
ZiQZ
′
iV
−1
i }ZiΣγ , and whereQ= (
∑I
i=1Z
′
iV
−1
i Zi)
−1 [Laird andWare (1982);
Verbeke and Molenberghs (2000)]. Expression (8) follows from the fact that
E[Φ(a+ V )] = Φ[(a+ µ)/
√
1 + τ2], where V ∼N(µ, τ2).
In the second stage, α0j (j = 1,2, . . . , J) and αp (p = 1,2, . . . , P ) can be
estimated by maximizing the likelihood
L=
I∏
i=1
[
Ji∏
j=2
{1−P (Yij = 1|Yi(j−1) = 0; X̂∗i )}
]
(9)
× P (Yi(Ji+1) = 1|YiJi = 0; X̂∗i )Ji<J ,
where P (Yij = 1|Yi(j−1 = 0, X̂∗i ) is given by (8). Thus, we propose the fol-
lowing algorithm for estimating α0j and αp (p= 1,2, . . . , P ):
1. Estimate the parameters of model (6) by fitting
(
P
2
)
bivariate models
to each of the pairwise combinations of longitudinal measurements and
averaging duplicate parameter estimates. The bivariate models can be fit
in R [Venables, Smith and the R Development Core Team (2008)] using
code presented in Doran and Lockwood (2006).
2. Simulate complete longitudinal pseudo measurements (i.e., Xpij for p=
1,2, . . . , P , i= 1,2, . . . , I , j = 1,2, . . . , J) from model (6) with model pa-
rameters estimated from step 1.
3. Estimate the parameters in model (2)–(3) without regard to the event
time distribution from complete longitudinal pseudo measurements (sim-
ulated in step 2) by fitting all possible
(
P
2
)
bivariate longitudinal models
and averaging duplicate model parameter estimates.
4. Calculate γ̂i using (7) and X̂
∗
pij using (3) with γi replaced by γ̂i and β
being replaced by β̂ estimated in step 3.
5. Estimate α0j (j = 2,3, . . . , J) and αp (p= 1,2, . . . , P ) using (8) and (9).
6. Repeat steps 2 to 5M times and average α̂0j and α̂p to get final estimates.
We choose M = 10 in the simulations and data analysis since this was
shown to be sufficiently large for univariate longitudinal modeling discussed
in Albert and Shih (2009). Asymptotic standard errors of α̂0j and α̂p cannot
be used for inference since they fail to account for the missing data uncer-
tainty in our procedure. Standard errors and 95% confidence intervals of
parameter estimates using the bootstrap [Efron and Tibshirani (1993)] are
as follows:
1. Construct a bootstrap sample of size I , by resampling event-time and
multivariate longitudinal data with replacement ((T bi ,X
b
1i,X
b
2i, . . . ,X
b
pi))
from the (Ti,X1i,X2i, . . . ,Xpi).
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2. Fit the proposed estimation procedure.
3. Iterate 500 times between steps 1 and 2. The bootstrap standard error is
the sample standard deviation of the 500 bootstrap estimates. The 95%
confidence intervals were constructed using the percetile method (limits
are 2.5 and 97.5 percentiles of the bootstrap distribution).
2.3. Incorporating covariate dependence. Covariates can be incorporated
in (3) by adding them directly into the multivariate linear mixed model
(6). Specifically, if X∗pij = Ziηp + βp0 + βp1tj + γpi0 + γpi1tj , where Zi is a
vector of covariates with ηp being parameters for the pth biomarker, then
P (Xi|Ti,Zi) =
∫
h(Xi|γi,Zi)g(γ i|Ti)dγi and Xi|Ti can be approximated by
a multivariate linear mixed model with Ziηp being added to the right side
of (6). Estimation then proceeds as described in Section 2.2 Although more
difficult, covariates can also be incorporated into (1). If
P (Yij = 1|Yi(j−1) = 0,X∗i ,Zi) = Φ
(
α0j +Ziζ +
P∑
p=1
αpX
∗
pi(j−1)
)
,(10)
then P (Xi|Ti,Zi) =
∫
h(Xi|γi,Zi)g(γ i|Ti,Zi)dγi, and under the assumption
that g(γi|Ti,Zi) is normally distributed with variance not depending on Zi
(which we found to be the case in simulations not shown), then Xi|Ti,Zi can
be approximated by a multivariate linear mixed model with Ziζ
∗
pTi
added to
the right-hand side of (6). Extensive simulations showed that the conditional
distribution of γi|Ti,Zi is nearly normally distributed over a wide range of
parameter values, with slight departures from normality found when the
relationship between the longitudinal process and event-time processes is
very strong (i.e., αp’s are very large in magnitude). The multivariate linear
model approximation is flexible in that it allows the regression parameters
to vary with Ti. A more parsimonious model would be to constrain the
parameters such that ζ∗pTi does not vary with Ti.
3. Simulations. We conduct a simulation study to examine the statis-
tical properties of the proposed approach. The approach is examined for
the situation where P = 3, I = 300, and σ2pε = 0.75 for p = 1,2 and 3. The
remaining parameters are presented in Table 1. We compare the proposed
approach with M = 10 with a model where the X∗pij ’s are assumed to be
known (true model) and with a model where the observed Xpij ’s are used in
(1) (observed model). Although the true values are never actually observed
in practice, we examine the true model as a benchmark in comparing the
other models. Table 1 shows that the proposed approach results in nearly
unbiased estimates of α1, α2 and α3, whereas the model which uses the ob-
served observations (which are subject to measurement error) has severe bias
for estimating α1 and α3 (the two parameters which are nonzero). Although
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Table 1
Estimates of α0j = α0, α1, α2 and α3 from model (1) with
σ1ε = σ2ε = σ3ε = 0.75 and with P = 3, J = 5, and I = 300. Random
effects are generated under a diagonal covariance matrix. Further, we
assume that tj = j and all individuals who are alive at t5 = 5 are
administratively censored at that time point. The means (standard
deviations) from 500 simulations are presented
Parameters True values Truth Proposed Observed
α0 −1.75 −1.77 −1.76 −1.37
(0.115) (0.180) (0.089)
α1 0.40 0.408 0.405 0.221
(0.060) (0.089) (0.042)
α2 0 0.00 0.00 0.001
(0.058) (0.077) (0.042)
α3 0.40 0.405 0.400 0.219
(0.062) (0.092) (0.043)
β10 1.0 1.00
(0.058)
β11 0 0.03
(0.068)
β20 0.5 0.50
(0.050)
β21 0 −0.01
(0.067)
β30 1 1.00
(0.052)
β31 0 0.023
(0.065)
σ2b10 0.25 0.277
(0.061)
σ2b11 0.25 0.296
(0.087)
σ2b20 0.25 0.268
(0.062)
σ2b21 0.25 0.286
(0.087)
σ2b30 0.25 0.270
(0.059)
σ2b31 0.25 0.294
(0.083)
the variability of parameter estimates is larger for the proposed approach
as compared with the observed approach, the root mean squared errors are
substantially smaller for α1 and α3 for the proposed approach. For exam-
ple, the root mean squared errors for α1 is 0.089 for the proposed approach
and 0.184 for the observed model. Results when the “true” values for the
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markers (markers without measurement errors) are assumed known are also
presented in Table 1 (column labeled Truth). As expected, estimates are
unbiased for this gold standard case. A comparison of the gold standard
case with the proposed approach shows efficiency loss. For example, the rel-
ative efficiency for estimating α1, α2 and α3 with the proposed approach
versus the gold standard is 0.45 [(0.06/0.089)2 ], 0.57 and 0.24, respectively.
We conducted additional simulations with different parameter values. In all
cases tried, the mean squared errors were substantially smaller using the
proposed approach as compared with using the observed values (data not
shown).
Table 1 also presents the average estimated intercept and slope for each of
the three longitudinal biomarkers. The results show that estimates of these
fixed effects are nearly unbiased for the proposed approach.
4. Example. We examine the effect of multiple longitudinal biomark-
ers on the short-term prognosis for patients with primary biliary cirrhosis
(PBC) using the PBC study conducted at the Mayo Clinic from 1974 to 1984
[Murtaugh et al. (1994)]. PBC is a chronic disease characterized by inflam-
matory destruction of the small bile ducts within the liver, which eventually
leads to cirrhosis of the liver, followed by death. Various biomarkers such
as biliribin, prothrombin time and albumin were collected longitudinally,
and interest is on examining whether these biomarkers relate to the natu-
ral history of disease. Of major interest was whether these biomarkers are
prognostic for transplantation-free survival (time to either transplantation
or death). A total of 312 patients had a baseline measurement and were
followed longitudinally at 6 months and at yearly intervals thereafter.
For our application, we focused on the first 4 years of follow-up for a
number of reasons. First, individual changes in the biomarkers appeared
to be close to linear over this time period. Figure 1 shows 4 examples of
complete follow-up in which the changes in log-transformed biliribin appear
to be linear over the first 4 years of follow-up and not very linear over the
whole range of follow-up. For each panel, the solid line is a least-squares
regression line for the first four years of follow-up, while the dashed line is a
corresponding line using all the follow-up data. The patterns over the whole
follow-up period are nonlinear curves and are not systematic over subjects,
and therefore not easily characterized by a simple nonlinear mixed model.
The reason why the linear assumption is reasonable over the shorter time
interval is that, even though the curves are nonlinear, they can adequately be
approximated as linear functions over a short time interval (i.e., a nonlinear
function can be locally approximated by a linear function). Second, the
methodology makes the assumption that the effect of the biomarkers on
prognosis is constant over the follow-up period [i.e., αp parameters in (1) do
MULTIVARIATE LONGITUDINAL AND TIME-TO-EVENT DATA 11
Fig. 1. Plot of log-transformed biliribin values versus follow-up time for 4 patients. Each
plot shows an example of complete follow-up in which the changes over time appear to be
linear over the first 4 years of follow-up and nonlinear over the entire length of follow-up.
For each panel, the solid line is a least-squares regression line for the first four years of
follow-up, while the dashed line is a corresponding line using all the follow-up data.
Table 2
The effect of log-transformed biliribin, prothrombin time and albumin on
transplantation-free survival. The analysis is based on fitting model (1)
with Xi(j−1) replacing X
∗
i(j−1). Time-to-event is modeled as a discrete
time process with possible event times at 0.5, 1, 2, 3 and 4 years, where
α02 reflects the baseline discrete-time event distribution for the intervals 0
to 0.5 and 0.5 to 1 years. The subsequent yearly intervals are characterized
by α03, α04, α05 and α06. 95% confidence intervals were estimated using
the bootstrap with the percentile method (500 bootstrap samples)
Parameters Estimate 95% confidence interval
α02 −3.71 −8.10 to −1.01
α03 −4.01 −8.51 to −1.14
α04 −3.37 −7.73 to −0.50
α05 −3.43 −7.91 to −0.39
α06 −3.39 −7.78 to −0.53
log Biliribin 0.58 0.45 to 0.74
log Albumin −2.57 −3.76 to −1.56
log Proth 1.86 0.79 to 3.53
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Table 3
The effect of log-transformed biliribin, prothrombin time and albumin
(p= 1, 2 and 3, respectively) on transplantation-free survival using the
proposed approach with M = 10. We fit model (1) with the true
longitudinal measurements following (2)–(3). Time-to-event is modeled as
a discrete time process with possible event times at 0.5, 1, 2, 3 and 4
years. Standard errors (SE) were estimated using the bootstrap. 95%
confidence intervals were estimated using the bootstrap with the percentile
method (500 bootstrap samples)
Parameters Estimate 95% confidence interval
α02 −5.22 −20.57 to −25.06
α03 −5.48 −21.06 to 24.83
α04 −4.05 −18.67 to 27.75
α05 −4.24 −17.88 to 27.45
α06 −4.48 −18.05 to 27.23
log Biliribin 0.34 0.02 to 1.71
log Albumin −11.39 −61.38 to −5.21
log Proth 6.16 −3.78 to 22.83
β10 0.50 0.22 to 0.58
β11 0.26 0.09 to 0.35
β20 1.26 0.56 to 1.27
β21 −0.05 −0.05 to −0.02
β30 2.36 1.06 to 2.38
β31 0.02 0.1 to 0.03
σ2b10 0.99 0.45 to 1.11
σ2b11 0.27 0.05 to 0.63
σ2b20 0.03 0.01 to 0.04
σ2b30 0.01 0.005 to 0.025
not vary over time]. This assumption is more reasonable over the shorter 4
year interval rather than the entire follow-up period.
Table 2 shows parameter estimates from fitting model (1) with the ob-
served data as covariates instead of the true values. Although both standard
errors and 95% confidence intervals were estimated using the bootstrap,
only the 95% confidence intervals are presented since the bootstrap esti-
mates were not normally distributed for many of the parameter estimates.
The results demonstrate a statistically significant positive effect of biliribin
and prothrombin time and a negative effect of albumin on transplantation-
free survival. However, it should be recognized that these parameter esti-
mates may be distorted due to the measurement error in these longitudinal
biomarker measurements.
Using the proposed approach, we initially fit model (1)–(3) which incor-
porated a random intercept and slope term for each of the three biomarkers.
However, the random effect for slope for prothrombin time and albumin were
estimated as nearly zero. Thus, we re-fit the model without a random slope
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effect for these two biomarkers. Table 3 shows parameter estimates from the
proposed approach with 95% confidence intervals estimated using the boot-
strap (as in the analysis with the observed biomarkers presented in Table 2,
we do not present the parameter estimates of the standard errors). Except
for the effect of biliribin, estimates of the other two biomarkers are substan-
tially larger in magnitude under the proposed approach than when ignoring
measurement error and using the observed data (Table 2). This is consistent
with the common phenomenon that ignoring measurement error attenuates
parameter estimates. In terms of inference, the effect of prothrombin time on
short-term prognosis is no longer statistically significant with the proposed
approach, while the effects of biliribin and albumin on prognosis are sta-
tistically significant with both approaches. In the PBC analysis, estimates
of σ2pε were 0.31, 0.12 and 0.11 for log-transformed values of biliribin, al-
bumin and prothrombin time, respectively. The smaller absolute values for
parameter estimates of albumin and prothrombin time using the observed
markers (Table 1) relative to estimates for these markers using the proposed
approach (Table 2) can be attributed to attenuation due to measurement
error, since, in these cases, the residual variances are substantially larger
than the between-subject variations.
We also conducted analyses where we adjusted for treatment effect and
age in the discrete-time survival model [Zi is treatment group or age in
model (10)]. As discussed in Section 2.3, we constrained the parameters
ζ∗pTi so that they did not vary with Ti (results were similar when we did not
constrain the parameters). When we adjusted for treatment group (with
treatment group coded as 1 for D-penicillamine and 0 for placebo) in (10),
we estimated the α coefficient corresponding to treatment as 0.051 (95% CI:
−0.84 to 1.14). The estimates of other parameters were almost identical to
those presented in Table 3. When we adjusted for age in (10), we estimated
the α coefficient corresponding to age as 0.018 (95% CI: 0.01 to 0.129), where
age was scaled in units of a year. Although age was statistically significant,
the effects of log bilirubin, albumin and prothtime on transplantation-free
survival were similar to those for the unadjusted model. Specifically, the
regression coefficients (α coefficients) corresponding to three markers are
0.394 (95% CI: 0.07 to 2.21), −10.65 (−83.51 to −5.52) and 5.76 (−4.28 to
30.97).
Table 3 also shows the estimated fixed effect intercept and slope for the
three longitudinal biomarkers for the proposed approach. The estimates sug-
gest that biliribin is increasing, while albumin and prothrombin time are
nearly constant over time.
The joint modeling approach is important in this application for a num-
ber of reasons. First, survival models which use observed biomarkers can
result in attenuated estimates of risk. The proposed approach allowed us
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to account for the measurement error in investigating the effect of multi-
ple biomarker measurements on the short-term prognosis of PBC patients
in terms of transplantation-free survival. With the proposed approach, we
found that the “true” biliribin and albumin values at the beginning of an
interval had a sizable and statistically significant effect on the probability of
either a transplantation or death in the subsequent interval. Second, the pro-
posed approach allows us to appropriately make inference about changes in
the three “true” biomarkers over time. As stated before, the largest change
over time was in biliribin which sizably increased over time. When making
these longitudinal inferences, not appropriately modeling the relationship
between the multiple biomarkers and survival may lead to bias due to infor-
mative dropout [Wu and Carroll (1988)].
5. Discussion. We proposed an approach for jointly modeling multivari-
ate longitudinal and discrete time-to-event data. Unlike likelihood-based ap-
proaches which require high-dimensional integration to evaluate the joint
likelihood, this approach only requires fitting bivariate random effects mod-
els. This methodology uses recent methodology for fitting multivariate lon-
gitudinal data with bivariate linear mixed models proposed by Fieuws et
al. (2005, 2007). They discussed the simple averaging of duplicate parame-
ters estimates as we did in implementing the proposed approach. They also
proposed a pseudo-likelihood approach which involves maximizing the sum
of likelihoods from bivariate models across all
(
P
2
)
combinations of pairwise
longitudinal markers. Although this later approach may provide some minor
efficiency gain over simple averaging, it would be substantially more com-
plicated to implement in our setting. Further, one of the advantages of the
pseudo-likelihood approach is that it provides an analytic expression for the
asymptotic variance of the parameter estimates. Unfortunately, this asymp-
totic variance is not generalizable to the joint model with time-to-event data,
making the pseudo-likelihood approach less attractive in our setting.
There are similarities between our approach and the recent approach by
Fieuws et al. (2008) for predicting renal graft failure based on multivariate
longitudinal profiles. Both approaches model the conditional distribution of
the multivariate longitudinal profiles given the failure time. However, there
are major differences between the two approaches. Fieuws et al. model the
conditional distribution of the longitudinal measurements given the failure
time and then use Bayes rule to estimate the probability of failure given
the longitudinal profiles. In our approach, we use an approximation of the
conditional distribution of Xi|Ti under the joint model of the multivariate
longitudinal and time-to-event data in order estimate the parameters of this
joint model.
We demonstrated the feasibility of the proposed approach with three
biomarkers (P = 3). However, the approach can easily accommodate a large
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number of longitudinal profiles since it simply involves fitting
(
P
2
)
bivariate
models. The relationship between the multivariate longitudinal and event-
time data is governed by expression (1). However, other functional relation-
ships are possible with this approach. For example, we could relate the two
processes by averages of “true” longitudinal biomarkers either across time
or across different biomarkers. Alternatively, the approach could be formu-
lated so that the event-time process depends on the individual’s intercept
and slope for each of the P longitudinal biomarkers.
The multivariate longitudinal profiles are modeled as multivariate linear
mixed models in (2) and (3), which was appropriate for the analysis of the
PBC data. However, the methodology could be extended to allow for more
flexible nonlinear modeling of marker profiles. This would involve approx-
imating the conditional probability Xi|Ti in (5) where h(Xi|γi) follows a
multivariate nonlinear mixed model, rather than the linear mixed model
discussed in our paper. In the nonlinear case, we could approximate (5) by
(6), where (6) would be a nonlinear mixed model with parameters indexed
by Ti rather than the linear mixed model presented. However, unless there is
biological rational for a particular nonlinear mixed model, it may be difficult
to choose a reasonable model in most practical situations.
In our formulation, we assumed that event times are only administratively
censored after a fixed follow-up at the end of the study. For the situation
in which patients are censored prematurely, dropout times can be imputed
based on a model fit using patients who had the potential to be followed
over the entire study duration.
In this article methodology was developed using a discrete-time survival
model with calibration error being incorporated by using a probit link func-
tion. This approach led to an analytically tractable form for incorporating
calibration error (8). For the PBC study, little is lost by using a discrete-
time model since the probability of an event in each of the five intervals
is low (the estimated probability of an event during each of the five time
intervals is 0.05, 0.03, 0.08, 0.07 and 0.07). For continuous-time survival
models such as the Cox model, incorporating calibration is more difficult
since there is no simple analytic solution. That said, we could use a Cox
model if we do not account for the calibration error in replacing the random
effect by their empirical Bayes estimators. Although not the case in the PBC
study, in situations where the within-subject variation is small relative to
the between-subject sources of variation, the calibration error will be small
and there will be only a small amount of bias induced by not accounting for
the calibration error.
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